<DOC>
	<DOCNO>NCT01563120</DOCNO>
	<brief_summary>Rationale Gestational diabetes mellitus ( GDM ) complicate 5-7 % pregnancy . Major hazard include macrosomia , polyhydramnios , labor trauma neonatal hypoglycemia . The ADA ACOG recommend glucose control order reduce incidence hyperglycemia induce complication . Glucose control achieve use diet life style change . Insulin initiate woman fail obtain glucose control diet alone . During past 11 year oral hypoglycemic drug test proven efficacious safe . Objectives 1 . To compare efficacy safety glybenclamide vs. metformin treatment woman diagnose GDM 2 . To evaluate improvement glycemic control addition second oral hypoglycemic drug failure first Hypothesis GDM one major condition contribute obstetrical complication prenatal morbidity . Improving glycemic control , mean improve compliance patient satisfaction , decrease obstetrical complication , maternal neonatal morbidity positive long term health implication . Study design Prospective , randomize , open label Study population Women age 18-45 , diagnose GDM recruit . GDM define pathological OGTT ( accord Carpenter Coustan criterion ) perform 13 week gestation . Study period From recruitment discharge newborn baby delivery Study protocol Women randomize recruitment . Demographic obstetrical data collect . Average glucose level previous two week , estimate fetal weight amniotic fluid index , lab exam reflect glycemic control note . Women provide daily glucose level via fax mail week . Glycemic control evaluate daily chart , include 7 measurement : 3 preprandial , 3 postprandial 7th measurement 10 pm . Women invite monthly follow-up , include sonographic evaluation fetal weight amniotic fluid , lab exam . Follow-up protocol 38 w gestation accord ward 's protocol . The study approve local Helsinki committee . Time table Duration : two year</brief_summary>
	<brief_title>A Comparison Between Two Oral Hypoglycemics - Metformin Glybenclamide Treatment Gestational Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>1 . Patients GDM gestational age 1433 week 2 . Fasting glucose 95 mg % 130 mg % hour half postprandial ( PPD ) daily average 100 mg % 3 . At least week dietary treatment 4 . Sonographic date pregnancy earlier 24 week 5 . Signing consent form 1 . Suspected IUGR earlier 24 week gestation 2 . Major fetal malformation 3 . Pregestational diabetes mellitus</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>